228 related articles for article (PubMed ID: 37696716)
1. Exosome-mediated metabolic reprogramming: Implications in esophageal carcinoma progression and tumor microenvironment remodeling.
Xi Y; Shen Y; Chen L; Tan L; Shen W; Niu X
Cytokine Growth Factor Rev; 2023 Oct; 73():78-92. PubMed ID: 37696716
[TBL] [Abstract][Full Text] [Related]
2. Exosome-mediated metabolic reprogramming: the emerging role in tumor microenvironment remodeling and its influence on cancer progression.
Yang E; Wang X; Gong Z; Yu M; Wu H; Zhang D
Signal Transduct Target Ther; 2020 Oct; 5(1):242. PubMed ID: 33077737
[TBL] [Abstract][Full Text] [Related]
3. Exosome-Derived Cargos in Immune Microenvironment in Esophageal Carcinoma: A Mini-Review.
Zhang Y; Sun X; Guan Y; Sun Y
Recent Pat Anticancer Drug Discov; 2024 Jan; ():. PubMed ID: 38173209
[TBL] [Abstract][Full Text] [Related]
4. Small extracellular vesicles in metabolic remodeling of tumor cells: Cargos and translational application.
Yang H; Wang J; Huang G
Front Pharmacol; 2022; 13():1009952. PubMed ID: 36588730
[TBL] [Abstract][Full Text] [Related]
5. Exosome-mediated cell-cell communication in tumor progression.
Wan Z; Gao X; Dong Y; Zhao Y; Chen X; Yang G; Liu L
Am J Cancer Res; 2018; 8(9):1661-1673. PubMed ID: 30323961
[TBL] [Abstract][Full Text] [Related]
6. Exosomes: Diagnostic and Therapeutic Implications in Cancer.
Jo H; Shim K; Jeoung D
Pharmaceutics; 2023 May; 15(5):. PubMed ID: 37242707
[TBL] [Abstract][Full Text] [Related]
7. Small Extracellular Vesicles in the Development, Diagnosis, and Possible Therapeutic Application of Esophageal Squamous Cell Carcinoma.
Zhao Z; Yang S; Zhou A; Li X; Fang R; Zhang S; Zhao G; Li P
Front Oncol; 2021; 11():732702. PubMed ID: 34527593
[TBL] [Abstract][Full Text] [Related]
8. Exosome derived from tumor-associated macrophages: biogenesis, functions, and therapeutic implications in human cancers.
Zhou M; He X; Mei C; Ou C
Biomark Res; 2023 Nov; 11(1):100. PubMed ID: 37981718
[TBL] [Abstract][Full Text] [Related]
9. Exo-MFA - A 13C metabolic flux analysis framework to dissect tumor microenvironment-secreted exosome contributions towards cancer cell metabolism.
Achreja A; Zhao H; Yang L; Yun TH; Marini J; Nagrath D
Metab Eng; 2017 Sep; 43(Pt B):156-172. PubMed ID: 28087332
[TBL] [Abstract][Full Text] [Related]
10. Exosomal cargos-mediated metabolic reprogramming in tumor microenvironment.
Tan S; Yang Y; Yang W; Han Y; Huang L; Yang R; Hu Z; Tao Y; Liu L; Li Y; Oyang L; Lin J; Peng Q; Jiang X; Xu X; Xia L; Peng M; Wu N; Tang Y; Cao D; Liao Q; Zhou Y
J Exp Clin Cancer Res; 2023 Mar; 42(1):59. PubMed ID: 36899389
[TBL] [Abstract][Full Text] [Related]
11. Exosomes-regulated lipid metabolism in tumorigenesis and cancer progression.
Ye L; Li Y; Zhang S; Wang J; Lei B
Cytokine Growth Factor Rev; 2023 Oct; 73():27-39. PubMed ID: 37291031
[TBL] [Abstract][Full Text] [Related]
12. Exosomes: composition, biogenesis, and mechanisms in cancer metastasis and drug resistance.
Mashouri L; Yousefi H; Aref AR; Ahadi AM; Molaei F; Alahari SK
Mol Cancer; 2019 Apr; 18(1):75. PubMed ID: 30940145
[TBL] [Abstract][Full Text] [Related]
13. Exosome-derived microRNAs in cancer metabolism: possible implications in cancer diagnostics and therapy.
Tomasetti M; Lee W; Santarelli L; Neuzil J
Exp Mol Med; 2017 Jan; 49(1):e285. PubMed ID: 28104913
[TBL] [Abstract][Full Text] [Related]
14. Role of exosomes in transferring chemoresistance through modulation of cancer glycolytic cell metabolism.
Vahabi M; Comandatore A; Franczak MA; Smolenski RT; Peters GJ; Morelli L; Giovannetti E
Cytokine Growth Factor Rev; 2023 Oct; 73():163-172. PubMed ID: 37541790
[TBL] [Abstract][Full Text] [Related]
15. The Effect of Hypoxia-Induced Exosomes on Anti-Tumor Immunity and Its Implication for Immunotherapy.
Guo W; Qiao T; Dong B; Li T; Liu Q; Xu X
Front Immunol; 2022; 13():915985. PubMed ID: 35812406
[TBL] [Abstract][Full Text] [Related]
16. Energy Sources for Exosome Communication in a Cancer Microenvironment.
Thakur A; Johnson A; Jacobs E; Zhang K; Chen J; Wei Z; Lian Q; Chen HJ
Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406470
[TBL] [Abstract][Full Text] [Related]
17. Lipid metabolic reprogramming in tumor microenvironment: from mechanisms to therapeutics.
Jin HR; Wang J; Wang ZJ; Xi MJ; Xia BH; Deng K; Yang JL
J Hematol Oncol; 2023 Sep; 16(1):103. PubMed ID: 37700339
[TBL] [Abstract][Full Text] [Related]
18. Exosomal Long Non-coding RNAs: Emerging Players in the Tumor Microenvironment.
Pathania AS; Challagundla KB
Mol Ther Nucleic Acids; 2021 Mar; 23():1371-1383. PubMed ID: 33738133
[TBL] [Abstract][Full Text] [Related]
19. Current Perspectives on the Unique Roles of Exosomes in Drug Resistance of Hepatocellular Carcinoma.
Xue D; Han J; Liang Z; Jia L; Liu Y; Tuo H; Peng Y
J Hepatocell Carcinoma; 2022; 9():99-112. PubMed ID: 35211428
[TBL] [Abstract][Full Text] [Related]
20. The Significance of Exosomes in Pathogenesis, Diagnosis, and Treatment of Esophageal Cancer.
Jing Z; Chen K; Gong L
Int J Nanomedicine; 2021; 16():6115-6127. PubMed ID: 34511909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
